| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |